ACAA2 is a novel molecular indicator for cancers with neuroendocrine phenotype

Stoyanova lab is excited to share our study on identifying ACAA2 as a potential new molecular indicator for cancers with neuroendocrine phenotype. Congratulations!

Link to publication: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667239/